Triple nutrient supplementation improves survival, infarct size and cardiac function following myocardial infarction in rats

被引:9
|
作者
Briet, Francoise [1 ,4 ,5 ]
Keith, Mary [2 ,4 ,5 ]
Leong-Poi, Howard [3 ,4 ,5 ]
Kadakia, Ankit [1 ,2 ]
Aba-Alkhail, Khalid [2 ]
Giliberto, John-Paul [2 ]
Stewart, Duncan [3 ,4 ,5 ,6 ]
Errett, Lee [2 ,4 ,5 ]
Mazer, C. David [1 ,4 ,5 ,6 ]
机构
[1] St Michaels Hosp, Dept Anesthesia, Toronto, ON M5B 1W8, Canada
[2] St Michaels Hosp, Div Cardiovasc Surg, Toronto, ON M5B 1W8, Canada
[3] St Michaels Hosp, Div Cardiol, Toronto, ON M5B 1W8, Canada
[4] St Michaels Hosp, Terrence Donnelly Heart Ctr, Toronto, ON M5B 1W8, Canada
[5] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada
[6] Univ Toronto, Dept Physiol, Toronto, ON, Canada
关键词
Carnitine; Coenzyme Q(10); Taurine; Cardioprotection; Myocardial infarction;
D O I
10.1016/j.numecd.2007.10.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aim: We evaluated the impact of triple nutrient supplementation (TNS: carnitine, taurine and coenzyme Q(10)) vs. carnitine atone (CARN) or placebo on survival, infarct size, cardiac function and metabolic gene expression using a model of myocardial infarction (MI) in rats. Methods and results: Male Wistar rats were randomized to three groups divided in two independent studies prior to ligation of the left anterior descending coronary artery (LAD): TNS vs. Placebo and TNS vs. CARN. Nutrient supplementation [L-carnitine (300 mg/day), coenzyme Q(10) (15 mg/kg body weight/day) and taurine (0.1 M)] was administered daily for four weeks prior to and for 10 days after MI. At that time, cardiac function and infarct size were measured. Metabolic gene (mRNA) expression in the peri-infarct tissue of left ventricle from TNS, placebo or corresponding time-control rats (TNS or placebo without LAD ligation) was measured 10 days after MI. When compared to placebo, TNS significantly improved survival (60% vs. 34%, p < 0.02), cardiac function, and reduced infarct size (30 +/- 7% vs. 42 +/- 9%, p < 0.001). Although CARN improved survival like TNS (45% vs. 50%, not significant), it did not reduce infarct size (32 +/- 14% vs. 19 +/- 10%, p < 0.05) or delay myocardial remodeling. In the placebo group, MI was associated with a significantly altered pattern of metabolic gene expression (glucose transporter 1, liver carnitine palmitoyl transferase 1, medium-chain acyl-CoA dehydrogenase; p < 0.01 for all three) in the left ventricle peri-infarct tissue. In contrast, gene expression was normalized in the group receiving TNS. Conclusions: Our results support the potential cardioprotective impact of TNS during myocardial ischemia. In contrast to carnitine supplementation atone, TNS improved survival as well as cardiac function, gene expression and delayed remodeling. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:691 / 699
页数:9
相关论文
共 50 条
  • [21] Oncostatin M promotes infarct repair and improves cardiac function after myocardial infarction
    Han, Hui
    Dai, Daopeng
    Du, Run
    Hu, Jinquan
    Zhu, Zhengbin
    Lu, Lin
    Zhu, Jinzhou
    Zhang, Ruiyan
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (10): : 11329 - 11340
  • [22] In vivo transfer of soluble TNF-alpha receptor 1 gene improves cardiac function and reduces infarct size after myocardial infarction in rats
    Sugano, M
    Tsuchida, K
    Hata, T
    Makino, N
    FASEB JOURNAL, 2004, 18 (03): : 911 - +
  • [23] Methotrexate carried in lipid core nanoparticles reduces myocardial infarction size and improves cardiac function in rats
    Maranhao, Raul C.
    Guido, Maria C.
    de Lima, Aline D.
    Tavares, Elaine R.
    Marques, Alyne F.
    de Melo, Marcelo D. Tavares
    Nicolau, Jose C.
    Mc Salemi, Vera
    Kalil-Filho, Roberto
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2017, 12 : 3767 - 3784
  • [24] Growth hormone improves cardiac function in rats with experimental myocardial infarction
    Isgaard, J
    Kujacic, V
    Jennische, E
    Holmang, A
    Sun, XY
    Hedner, T
    Hjalmarson, A
    Bengtsson, BA
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1997, 27 (06) : 517 - 525
  • [25] N-ethylmaleimide-sensitive factor siRNA improves cardiac function following myocardial infarction in rats
    Zhou, Y.
    Liu, Y.
    Yang, S. X.
    Wang, Z.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (03) : 9478 - 9485
  • [26] EFFECTS OF PHARMACOLOGICAL INTERVENTION ON INFARCT SIZE FOLLOWING INDUCED MYOCARDIAL-INFARCTION IN RATS
    BARLETTA, MA
    STAAB, R
    CAM, CL
    LYNCH, VD
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (11) : 1643 - 1645
  • [27] Early association of electrocardiogram alteration with infarct size and cardiac function after myocardial infarction
    陶则伟
    黄元伟
    夏强
    傅军
    赵志宏
    陆贤
    BRUCE I.C.
    Journal of Zhejiang University Science, 2004, (04) : 124 - 128
  • [28] Resveratrol reduces infarct size and improves ventricular function after myocardial ischemia in rats
    Lin, Jeng-Feng
    Lin, Su-Man
    Chih, Chun-Lien
    Nien, Mao-Wei
    Su, Hsin-Hui
    Hu, Bo-Ruei
    Huang, Shiang-Suo
    Tsai, Shen-Kou
    LIFE SCIENCES, 2008, 83 (9-10) : 313 - 317
  • [29] Wogonin reduces infarct size and improves ventricular function in chronic myocardial ischemia rats
    Lin, Su-Man
    Tsai, Shen-Kou
    Chih, Chun-Lien
    Nien, Mao-Wei
    Huang, Shiang-Suo
    FASEB JOURNAL, 2012, 26
  • [30] An allogeneic bioengineered myocardial graft limits infarct size and improves cardiac function: pre-clinical study in the porcine myocardial infarction model
    Perea Gil, I. Isaac
    Prat-Vidal, C.
    Galvez-Monton, C.
    Roura, S.
    Llucia-Valldeperas, A.
    Soler-Botija, C.
    Diaz-Guemes, I.
    Crisostomo, V.
    Sanchez-Margallo, F. M.
    Bayes-Genis, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 425 - 425